Bailly-Creat

Profile narrative

Bailly-Creat operates as a pharmaceutical laboratory with its headquarters located in France. The organisation focuses on the research, development, and production of medicinal products intended for human use. Its activities involve the typical functions of a pharmaceutical laboratory, such as research, development, and production of medicinal products. By concentrating on pharmaceuticals, Bailly-Creat contributes to the supply chain of therapies that address various medical conditions. The laboratory’s work is carried out under the regulatory framework applicable to the French and European pharmaceutical sectors.

The source material does not disclose quantitative details such as the organisation’s workforce size, annual revenue, or number of facilities. Consequently, any description of its scale must be based solely on the qualitative information available. Bailly-Creat’s known presence is limited to its French headquarters, with no additional geographic locations mentioned in the provided references. The absence of published metrics prevents a more precise characterisation of its market reach or operational footprint.

As a pharmaceutical laboratory, Bailly-Creat specialises in the creation and testing of drug substances, which places it within a highly regulated industry. The nature of its work involves handling confidential formulation data, clinical trial information, and proprietary manufacturing processes. This concentration on sensitive intellectual property makes the organisation an attractive target for threat actors seeking valuable corporate data. The November 2020 Doppel ransomware incident demonstrated how attackers can infiltrate such environments, exfiltrate documents, and later release portions of the stolen information without issuing a ransom demand. The episode underscores the importance of robust cybersecurity controls for entities that manage critical health‑related data.

Information regarding Bailly-Creat’s ownership structure, parent companies, or subsidiary relationships is not present in the supplied sources. Therefore, any description of its corporate governance or affiliations would be speculative and is omitted here. The organisation is identified solely by its alias Bailly-Creat and its French headquarters location. Further details about its legal status or organisational hierarchy would require additional disclosures beyond those currently available.

Incidents

1 incident linked to this organisation.